Has Edgar Robertson received payments from drug or device companies?

Yes. Drug and device makers reported $22,610 in general payments to Edgar Robertson across 386 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Edgar Robertson did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Edgar Robertson come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Edgar Robertson

Neurology · Peabody, MANPI 1003885203

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (42.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 43 manufacturers reported payments, led by Amgen at 38.5% of the total. Reporting peaked in 2019 at $15,282 and has fallen 99.8% since, to $35 in 2025.

$22,610in general payments, 2019–2025

Across 386 payments — averaging $58.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Amgen$9K
Biogen$5K
Teva Pharmaceuticals USA, Inc.$3K
AbbVie$1K
Bristol Myers Squibb$578
Novartis$510
plus $3K from 37 others

What the payments were for

Consulting fees$3,57516%
Speaking & faculty fees$9,62243%
Travel & lodging$1,8788%
Food & beverage$7,53533%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Amgen(2 entities)	21	$8,711
Biogen	43	$5,053
Teva Pharmaceuticals USA, Inc.	19	$3,150
AbbVie(2 entities)	57	$1,219
Bristol Myers Squibb	64	$578
Novartis	29	$510
Lilly USA, LLC	15	$298
UCB, Inc.	11	$290
SK Life Science, Inc.	8	$196
Sanofi	9	$196
Sunovion Pharmaceuticals Inc.	10	$185
Acorda Therapeutics, Inc	10	$181
Amneal Pharmaceuticals LLC	9	$167
EMD Serono, Inc.	5	$142
Avanir Pharmaceuticals, Inc.	6	$130
Johnson & Johnson	5	$128
Pfizer	4	$107
Genentech USA, Inc.	6	$105
Kyowa Kirin, Inc.	4	$104
Neurocrine Biosciences, Inc.	4	$104
Biohaven Pharmaceuticals, Inc.	3	$98
GE HealthCare	4	$91
Acadia Pharmaceuticals Inc	4	$73
Ipsen Biopharmaceuticals, Inc	3	$72
Eisai Inc.	3	$66
Greenwich Biosciences, Inc.	3	$66
Supernus Pharmaceuticals, Inc.	1	$65
MDD US Operations, LLC	4	$64
Livanova USA, Inc.	3	$62
Biohaven Pharmaceutical Holding Company Ltd.	2	$50
Grifols USA, LLC	2	$43
Avion Pharmaceuticals	2	$42
Banner Life Sciences, LLC	2	$40
E.r. Squibb & Sons, L.L.C.	2	$38
Cala Health, Inc.	1	$27
Lundbeck LLC	1	$27
Takeda Pharmaceuticals U.S.A., Inc.	1	$22
Neuropace, Inc.	1	$21
Merz North America, Inc.	1	$21
AstraZeneca	1	$20
Vertical Pharmaceuticals, LLC	1	$18
Tanabe Pharma America, Inc.	1	$18
Shire North American Group Inc	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AIMOVIG$8,452
AJOVY$2,937

How this compares

$22,610 in reported general payments places this provider in the 85th percentile of 761 neurology providers in Massachusetts.

See all neurology providers in Massachusetts →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sumatriptan Succinate	18	$1,294
Levetiracetam	21	$613
Topiramate	21	$417

Paid to pharmacies, not to this prescriber.

Other neurology in Peabody

Christopher WrightBoston$2.5M
Shivang JoshiWestborough$1.2M
Egilius SpieringsWellesley Hills$680K
Thomas ScammellBoston$617K
Salvatore NapoliFoxboro$613K
Alfred SandrockBoston$490K
Joshua KatzWellesley$462K
Guy BuckleBrookline$450K
Pushpa NarayanaswamiBoston$420K
Kenneth GorsonWellesley$414K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →